Human prothrombin complex (Guangdong Shuanglin)

人凝血酶原复合物（广东双林）

Report date: 2026/04/13 20:02:18

Base Information

Drug NameHuman prothrombin complex (Guangdong Shuanglin)
Drug Alias NameN/A
ClassificationBiologics > Blood components
Mechanisms of ActionCoagulation factor VII modulatorsCoagulation factor X modulatorsCoagulation factor IX modulators +[4] 
TargetsCoagulation factor VIIProthrombinCoagulation factor IX +[4] 
Therapy Area/IndicationsHemorrhageHemophilia B
Global Approved IndicationsHemophilia B
Approved Indications in ChinaHemophilia B
Original Approved Country/TerritoryMainland China
Original Approved Date2023/05/12
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGuangdong Shuanglin Bio-Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGuangdong Shuanglin Bio-Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHemorrhageHemophilia B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A